← Back to catalogue
Research draft

pancreas

vr.tr.pancreas · PHY.OBJ

Enable an AI agent to recognise a pancreas, distinguish its structural and functional states, and identify what assessment or intervention may be appropriate given the evidence and authority available.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Codex

Purpose and description

Enable an AI agent to recognise a pancreas, distinguish its structural and functional states, and identify what assessment or intervention may be appropriate given the evidence and authority available.

It can be Map pancreatic regions, ducts and neighbouring structures from documented observations.; Compare serial imaging and functional evidence while preserving method and timing differences.; Identify missing evidence needed to distinguish exocrine failure, endocrine dysfunction and structural disease.; Flag documented duct obstruction, tissue compromise or other concerning findings for qualified clinical review.; Assess whether proposed sampling, drainage, resection or graft monitoring has sufficient anatomical evidence and clinical authorization..

Distinguishing features

A typical native pancreas has a head associated with the duodenum and a body and tail extending toward the spleen; location alone is insufficient for ectopic tissue or a transplant.

Pancreatic tissue combines exocrine acinar and ductal components with endocrine islets; an individual sample may not capture all components.

Pancreatic ducts carry exocrine secretions toward the duodenum, distinguishing the organ from adjacent lymph nodes, spleen and adrenal tissue.

The pancreas produces digestive secretions and endocrine hormones, whereas the gallbladder stores bile; shared drainage relationships do not make them the same organ.

A mass near the pancreas requires evidence of pancreatic origin or continuity before it is treated as part of the organ.

Scope

+ Pancreatic identity, anatomical regions, variants and remaining organ extent

+ Pancreatic ducts and their connections to digestive drainage pathways

+ Exocrine secretion and evidence of effective digestive enzyme delivery

+ Endocrine tissue function and evidence of pancreatic hormone secretion

+ Local tissue changes, lesions and pancreatic complications

+ Pancreas-specific assessment, preservation and intervention constraints

- Whole-person diagnosis, treatment planning and consent

- Systemic glucose regulation and diabetes management beyond pancreatic contribution

- Liver, gallbladder and extra-pancreatic biliary tract structure and disease

- Duodenal and intestinal function beyond their interface with pancreatic drainage

- Detailed classification and staging of pancreatic tumours as disease entities

- Procedural equipment, surgical technique and transplant allocation systems

Characteristics

Host and organ context
Host organism; native organ, graft, remnant or isolated specimen Connects observations to the correct organ and determines which anatomical and functional expectations apply.
Anatomical extent
Head, uncinate process, neck, body and tail present, absent, altered or uncertain Distinguishes a complete organ from congenital variation, resection or incomplete observation.
Regional dimensions
Millimetres or millilitres, with region, imaging method and observation date Supports comparison over time without assuming one universal normal size.
Duct configuration and patency
Observed duct course and connections; patent, narrowed, obstructed, disrupted or uncertain; diameter in millimetres Determines whether pancreatic secretions have an intact drainage route.
Exocrine capacity
Preserved, impaired, unassessed or indeterminate, with supporting test and context Separates digestive secretory capacity from appearance and endocrine function.
Endocrine secretory capacity
Evidence of preserved, reduced or inappropriate secretion, or indeterminate status, by hormone and test context Avoids treating a systemic glucose result as a direct measurement of the entire pancreas.
Parenchymal condition
Observed oedema, atrophy, fibrosis, fatty replacement, calcification, necrosis or no detected abnormality Records tissue changes that may affect function, viability or intervention.
Focal abnormality
Linked lesion with region, size, solid or cystic appearance, duct relationship and evidential status Locates abnormalities without making an imaging description equivalent to a confirmed diagnosis.
Perfusion and vascular relationships
Observed perfusion and relationships to named vessels; preserved, compromised or uncertain Supports assessment of tissue viability and constraints on sampling or intervention.

Also called

human pancreas

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 5 bundles · 10 layers · 10 findings · 20 questions.

Pancreatic identity and anatomy Establishes which pancreas or pancreatic tissue is being described and its anatomical extent.

Native organs, remnants, grafts and ectopic tissue require different expectations for recognition and boundaries.

Organ context

Connects pancreatic identity to the host and acquisition or surgical history.

Pancreatic identity

Records the evidence that the observed structure is pancreatic tissue and identifies its organ context.

  1. What anatomical, operative or histological evidence establishes that this structure is pancreas? definition
  2. Is this a native pancreas, graft, postoperative remnant or isolated specimen, and which record establishes that context? provenance

Regional extent

Maps pancreatic regions and variations without assuming typical anatomy.

Pancreatic region map

Identifies present, altered, absent and unobserved regions and their neighbouring structures.

  1. Which pancreatic regions are present, resected, congenitally variant or not adequately visualised? boundary
  2. What are the measured regional dimensions, and which modality and date produced them? measurement
Exocrine production and drainage Separates pancreatic digestive secretion from its delivery through the duct system.

Secretory impairment and blocked or disrupted drainage can produce different states and require different assessments.

Duct system

Describes pancreatic duct anatomy and the continuity of drainage.

Duct continuity and outflow

Records duct configuration, calibre, narrowing, obstruction and leakage evidence.

  1. What main and accessory duct configuration and drainage connections are demonstrated? boundary
  2. Where are duct dilatation, narrowing, obstruction or disruption observed, and how were they established? measurement

Digestive secretory capacity

Assesses evidence that pancreatic exocrine output supports digestion.

Exocrine function evidence

Distinguishes demonstrated exocrine impairment from symptoms or structural changes alone.

  1. Which tests support the assessment of exocrine function, with what results, units and specimen conditions? measurement
  2. What evidence separates reduced pancreatic secretion from impaired delivery or a non-pancreatic cause of maldigestion? boundary
Endocrine secretory function Represents pancreatic hormone secretion and the limits of attributing systemic findings to the organ.

Endocrine and exocrine function can differ, and glucose disturbance alone does not establish pancreatic secretory failure.

Hormone output

Records hormone-specific evidence under interpretable sampling conditions.

Endocrine capacity evidence

Captures evidence of deficient, preserved or inappropriate pancreatic endocrine secretion.

  1. Which pancreatic hormone or secretion proxy was assessed, and what were the result, units and reference context? measurement
  2. What concurrent glucose level, fasting or stimulation state, medication exposure and relevant clearance factors affect interpretation? provenance

Pancreatic attribution

Connects endocrine observations to pancreatic tissue while retaining alternative explanations.

Endocrine source and extent

Distinguishes organ-level loss of capacity from focal secretion and systemic influences.

  1. What evidence attributes the endocrine finding to pancreatic tissue rather than systemic demand, medication or altered clearance? boundary
  2. Is the finding linked to tissue loss, a focal pancreatic lesion or an unresolved source? definition
Pancreatic tissue and lesions Describes diffuse tissue changes, focal abnormalities and their evolution.

Pancreatic state requires explicit separation of observed morphology, inferred disease and confirmed pathology.

Diffuse tissue condition

Records regional or widespread changes in pancreatic parenchyma.

Parenchymal change

Tracks tissue appearance and viability with the evidential limits of each observation.

  1. Which regions show oedema, atrophy, fibrosis, fatty replacement, calcification or suspected necrosis, and by what method? measurement
  2. Which changes are directly observed, which are inferred, and what comparable prior evidence establishes progression or resolution? provenance

Focal abnormalities

Locates lesions and records their relationship to ducts and surrounding tissues.

Lesion origin and character

Distinguishes a pancreatic lesion from an adjacent abnormality and separates description from diagnosis.

  1. What establishes pancreatic origin, and how does the abnormality relate to pancreatic ducts and neighbouring structures? boundary
  2. What are its size, location, solid or cystic features and interval changes, and is any diagnostic classification supported by tissue sampling? measurement
Pancreatic intervention constraints Records organ-specific anatomy, prior alterations and functional consequences relevant to proposed actions.

Sampling, drainage and resection depend on duct and vascular relationships and may affect digestive and endocrine capacity.

Access and preservation

Captures anatomy and tissue status that constrain access and preservation.

Duct and vessel exposure

Identifies pancreatic ducts, vascular relationships and viable tissue relevant to an intended intervention.

  1. Which ducts, vessels and adjacent organs lie within or near the proposed intervention area? boundary
  2. What additional mapping or viability assessment does the responsible clinician require before sampling, drainage or resection? action

Altered pancreas follow-up

Connects surgical or transplant anatomy with drainage, tissue viability and remaining function.

Post-intervention pancreatic state

Records how an intervention changed pancreatic extent, connections and monitoring needs.

  1. What pancreatic tissue and drainage connections remain or were reconstructed, according to the operative record? provenance
  2. Which clinician-defined observations are required to assess leakage, obstruction, perfusion and remaining exocrine or endocrine function? action

What the second pass must settle

  • Does the registry intend a human-specific pancreas model or a species-general model requiring distinct anatomical and physiological profiles?
  • Should ectopic pancreatic tissue and isolated islet preparations be represented as instances, parts or related entities under the registry's granularity rules?
  • Which measurements and reference frameworks are sufficiently validated across age, body size, imaging modality and postoperative anatomy?
  • What evidence thresholds should distinguish descriptive pancreatic observations from confirmed functional impairment or disease attribution?
  • Which assessment and escalation rules should the model reference for native organs, remnants and grafts, and which belong exclusively to linked clinical protocols?